Patent assignee · GB · COMPANY

SYNTAXIN, LTD.

36Patents
33Active
36Granted
53Portfolio score

Filing activity: Dec 4, 2000 → Jul 17, 2013 · 19 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US7658933B2 Non-cytotoxic protein conjugates Chemistry; Metallurgy 33 Active
US7659092B2 Fusion proteins Chemistry; Metallurgy 31 Active
US7452543B2 Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics Human Necessities 31 Expired
US8067200B2 Fusion proteins Chemistry; Metallurgy 29 Active
US8187834B2 Non-cytotoxic protein conjugates Chemistry; Metallurgy 23 Active
US7887810B2 Clostridial toxin derivatives able to modify peripheral sensory afferent functions Emerging Cross-Sectional Technologies 22 Active
US7892560B2 Clostridial toxin derivatives able to modify peripheral sensory afferent functions Emerging Cross-Sectional Technologies 22 Active
US7727538B2 Methods and compounds for the treatment of mucus hypersecretion Chemistry; Metallurgy 17 Active
US8603779B2 Non-cytotoxic protein conjugates Chemistry; Metallurgy 16 Active
US8481040B2 Carrier for targeting nerve cells Emerging Cross-Sectional Technologies 14 Active
US8512984B2 Non-cytotoxic protein conjugates Chemistry; Metallurgy 14 Active
US8399401B2 Fusion proteins Chemistry; Metallurgy 12 Active
US8124074B2 Fusion proteins Chemistry; Metallurgy 10 Active
US7368532B2 Constructs for delivery of therapeutic agents to neuronal cells Chemistry; Metallurgy 10 Expired
US7470661B2 Delivery of superoxide dismutase to neuronal cells Chemistry; Metallurgy 9 Expired
US8399400B2 Fusion proteins Chemistry; Metallurgy 9 Active
US8940870B2 Fusion proteins Chemistry; Metallurgy 8 Active
US8778634B2 Non-cytotoxic protein conjugates Chemistry; Metallurgy 8 Active
US8790897B2 Treatment of mucus hypersecretion Chemistry; Metallurgy 6 Active
US9072736B2 Treatment of pain Chemistry; Metallurgy 6 Active
US7674470B2 Recombinant toxin fragments Emerging Cross-Sectional Technologies 6 Active
US7897158B2 Recombinant toxin fragments Emerging Cross-Sectional Technologies 5 Active
US8372615B2 Fusion proteins Chemistry; Metallurgy 5 Active
US8124405B2 Fusion proteins Chemistry; Metallurgy 4 Active
US8796216B2 Suppression of neuroendocrine diseases Chemistry; Metallurgy 4 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.